Skip to the page

Data / Drug companies / Teva Czech Industries S.r.o

Teva Czech Industries S.r.o: 43 products in the FDA NDC directory, labeler code 47848

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Teva Czech Industries S.r.o (labeler code 47848) lists 43 products in the FDA National Drug Code Directory. By type: 43 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on December 14, 2023.

The request: Watch Teva Czech Industries S.r.o (FDA labeler code 47848): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
47848
Products in commercial distribution
43
Packages
46
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule III 3, Schedule IV 1
Started marketing in the last 12 months
0
Earliest marketing start
January 4, 2012
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients43100%

Products by type

TypeProductsShare
Bulk ingredients43100%

Dosage forms

Dosage formProductsShare
Powder43100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Zavegepant hcl47848-062PowderBulk ingredientsDecember 14, 2023
Ozanimod hcl47848-061PowderBulk ingredientsSeptember 25, 2023
Dihydroergotoxine mesylate47848-002PowderBulk ingredientsNovember 29, 2022
Selexipag47848-060PowderBulk ingredientsSeptember 26, 2022
Voclosporin47848-059PowderBulk ingredientsApril 4, 2022
Pemetrexed47848-026PowderBulk ingredientsJanuary 26, 2022
Galanthamine hydrobromide47848-023PowderBulk ingredientsJanuary 26, 2022
Ergonovine maleate47848-012PowderBulk ingredientsJanuary 26, 2022
Cyclosporine47848-004PowderBulk ingredientsJanuary 26, 2022
Ergotamine tartrate47848-001PowderBulk ingredientsJanuary 26, 2022
Palonosetron hydrochloride47848-027PowderBulk ingredientsJanuary 24, 2022
Mycophenolate mofetil47848-019PowderBulk ingredientsMay 14, 2021
Tacrolimus47848-018PowderBulk ingredientsMay 5, 2020
Pergolide mesylate47848-008PowderBulk ingredientsSeptember 3, 2019
Paliperidone palmitate47848-058PowderBulk ingredientsAugust 21, 2019
Fluticasone furoate47848-057PowderBulk ingredientsOctober 2, 2018
Methylergometrine maleate47848-021PowderBulk ingredientsJune 22, 2018
Bromocriptine mesylate micronize47848-003PowderBulk ingredientsDecember 29, 2017
Cabergoline47848-009PowderBulk ingredientsDecember 18, 2017
Paclitaxel semisynthetic47848-034PowderBulk ingredientsNovember 21, 2017
Dihydroergotamine mesylate47848-006PowderBulk ingredientsNovember 21, 2017
Obeticholic acid47848-056PowderBulk ingredientsDecember 13, 2016
Umeclidinium bromide47848-055PowderBulk ingredientsNovember 8, 2016
Vilanterol trifenatate47848-054PowderBulk ingredientsOctober 26, 2016
Rolapitant47848-053PowderBulk ingredientsJuly 25, 2016

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.